Robert Schreiber

20PUBLICATIONS
85CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 16, 2026
CD4+ T cells play distinct roles during the priming versus effector phases of immune checkpoint therapy-dependent tumor elimination by CD8+ T cells.

|Apr 17, 2026
Immune Checkpoint Therapy Drives Maturation of a Cellular Neighborhood Nucleated by T Cell-APC Triads Enabling Spatially Compartmentalized Tumor Immunity.

|Apr 15, 2026
mRNA vaccines engage unconventional pathways in CD8+ T cell priming.

|Jan 19, 2026
Radionuclide-stimulated dynamic therapy induces complementary immunogenic necroptosis and apoptosis cancer cell death pathways.

Christopher Egbulefu, Kvar Black, Xinming Su

|Jul 24, 2024
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy.

Hussein Sultan, Yoshiko Takeuchi, Jeffrey P Ward

|May 20, 2024
Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry.

Wei Meng, Yoshiko Takeuchi, Jeffrey P Ward

Pageof 4

Frequent Collaborators

11 joint publications

Philip D Greenberg

10 joint publications

Elaine R Mardis

9 joint publications

Kenneth C Anderson

9 joint publications

Massimo Loda